androstenedione has been researched along with buserelin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (23.53) | 18.7374 |
| 1990's | 24 (70.59) | 18.2507 |
| 2000's | 2 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, CY; Ziebe, S | 1 |
| Coombes, RC; Dowsett, M; Stein, RC | 1 |
| Caruso, A; Fulghesu, AM; Guida, C; Lanzone, A; Le Donne, M; Mancuso, S; Nicoletti, MC; Rossi, P | 1 |
| Balint-Perić, L; Prelević, GM; Wurzburger, MI | 1 |
| Abyholm, T; Dale, PO; Djøseland, O; Jervell, J; Tanbo, T | 1 |
| Coombes, RC; Ford, HT; Gazet, JC | 1 |
| Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC | 1 |
| De Sutter, P; Dhont, M; Vandekerckhove, D; Vanluchene, E | 1 |
| Gör, U; Grunwald, K; Papp, Z; Rabe, T; Runnebaum, B; Schulte, B; Urbancsek, J | 1 |
| Andreani, CL; Caruso, A; Fulghesu, AM; Lanzone, A; Le Donne, M; Mancuso, S; Muscatello, R; Pappalardo, S; Proto, C | 1 |
| Conaglen, JV; Gordon, P; Lowy, C; Macleod, AF; Sönksen, PH; Wheeler, MJ | 1 |
| Ayub, M; Levell, MJ | 1 |
| Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC | 1 |
| Distler, W; von Matthiessen, H | 1 |
| Eidtmann, H; Jonat, W; Kügler, G; Kunz, T; Maass, H | 1 |
| Devesa, J; Leite, V; Sobrinho, LG; Valdés, L | 1 |
| Alvarez, S; Antoine, JM; Cornet, D; Firmin, C; Mandelbaum, J; Plachot, M; Salat-Baroux, J; Tibi, C | 1 |
| Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA | 1 |
| Blamey, RW; Nicholson, RI; Read, GF; Robertson, JF; Turkes, A; Walker, KJ; Walker, RF | 1 |
| Franssen, AM; Rolland, R; Vemer, HM; Willemsen, WN | 1 |
| Beaur, A; Bourreau, E; Parinaud, J; Pontonnier, G; Vieitez, G | 1 |
| Black, WP; Coutts, JR; Fleming, R | 1 |
| Bélanger, A; Dubé, JY; Frenette, G; Labrie, F; Tremblay, RR; Tremblay, Y | 1 |
| Fraser, HM | 1 |
| Fraser, HM; Jonassen, J; Popkin, R | 1 |
| Bertoli, A; Di Daniele, N; Fusco, A; Gatti, S; Lauro, R; Magnani, A; Marini, MA | 1 |
| Donaldson, A; Franks, S; Leigh, A; White, D; Wilson, C | 1 |
| Andronis, CK; Chlouverakis, CS; Devetzaki, OA; Hatziioanidis, AH; Kounadi, TG; Misichronis, GS; Piaditis, GP; Rangou, DB; Trovas, GP | 1 |
| Chlouverakis, CS; Piaditis, GP; Rangou, DB; Spina, J; Stamataki, KE | 1 |
| Chao, KH; Chen, HF; Chen, SU; Ho, HN; Huang, SC; Lee, TY; Wu, MY; Yang, YS | 1 |
| Akaboshi, K; Kohriyama, S; Miyazaki, T; Oda, T; Yoshida, J; Yoshimura, Y | 1 |
| Bayram, F; Keleştimur, F; Sahin, Y; Tutuş, A; Unlühizarci, K | 1 |
| Abyholm, T; Dale, PO; Fedorcsák, P; Storeng, R; Tanbo, T | 1 |
| Furui, T; Imai, A; Ohno, T; Sugiyama, M; Tamaya, T | 1 |
3 review(s) available for androstenedione and buserelin
| Article | Year |
|---|---|
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogens; Female; Goserelin; Humans; Menopause | 1992 |
New trends in the endocrine treatment of breast cancer.
Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
The effects of buserelin on the hormonal states in PCOD.
Topics: Adult; Androstenedione; Buserelin; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Ovulation Induction; Polycystic Ovary Syndrome; Testosterone | 1986 |
7 trial(s) available for androstenedione and buserelin
| Article | Year |
|---|---|
Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study).
Topics: Adult; Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Pilot Projects; Receptors, Estrogen | 1991 |
Primary systemic therapy for operable breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen | 1991 |
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
Topics: Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Ovariectomy | 1990 |
New trends in the endocrine treatment of breast cancer.
Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
[Ovarian stimulation for in vitro fertilization using LHRH agonists: comparison of plasma and intra-follicular hormone profiles using "short" and "long" protocols].
Topics: Adult; Androstenedione; Buserelin; Clinical Protocols; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Luteinizing Hormone; Luteolytic Agents; Ovulation Induction; Pregnancy; Pregnancy Outcome; Progesterone; Prolactin; Retrospective Studies; Testosterone; Triptorelin Pamoate | 1990 |
Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
Topics: Adolescent; Adult; Androstane-3,17-diol; Androstenedione; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Hirsutism; Humans; Luteinizing Hormone; Menstruation Disturbances; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors | 1995 |
The effects of gonadotropin-releasing hormone agonist on androstenedione production and follicular development during controlled ovarian hyperstimulation.
Topics: Adult; Androstenedione; Buserelin; Embryo Transfer; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Follicular Atresia; Gonadotropins; Humans; Infertility, Female; Luteinizing Hormone; Male; Ovarian Follicle; Pregnancy; Progesterone; Prospective Studies | 1998 |
25 other study(ies) available for androstenedione and buserelin
| Article | Year |
|---|---|
Serum levels of free androstenedione, testosterone and oestradiol are lower in the follicular phase of conceptional than of non-conceptional cycles after ovarian stimulation with a gonadotrophin-releasing hormone agonist protocol.
Topics: Analysis of Variance; Androstenedione; Buserelin; Carrier Proteins; Enzyme-Linked Immunosorbent Assay; Female; Fertilization in Vitro; Follicular Phase; Humans; Ovulation Induction; Pregnancy; Progesterone; Sex Hormone-Binding Globulin; Testosterone | 1992 |
Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
Topics: Adult; Analysis of Variance; Androstenedione; Anovulation; Biological Assay; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menotropins; Ovary; Ovulation Induction; Pituitary Gland; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone | 1992 |
The effect of somatostatin analog octreotide (Sandostatin) on luteinizing hormone and ovarian steroids in insulin-dependent diabetic women without residual insulin secretion.
Topics: Adult; Androstenedione; Buserelin; Diabetes Mellitus, Type 1; Estradiol; Female; Follicle Stimulating Hormone; Humans; Insulin; Insulin Secretion; Luteinizing Hormone; Octreotide; Ovary; Periodicity; Steroids; Testosterone | 1992 |
Persistence of hyperinsulinemia in polycystic ovary syndrome after ovarian suppression by gonadotropin-releasing hormone agonist.
Topics: Adult; Androstenedione; Blood Glucose; Buserelin; Female; Glucose Tolerance Test; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Testosterone | 1992 |
Correlations between follicular fluid steroid analysis and maturity and cytogenetic analysis of human oocytes that remained unfertilized after in vitro fertilization.
Topics: 17-alpha-Hydroxyprogesterone; 20-alpha-Dihydroprogesterone; Androstenedione; Buserelin; Chromosomes; Clomiphene; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Goserelin; Humans; Hydroxyprogesterones; Karyotyping; Male; Menotropins; Oocytes; Ploidies; Progesterone; Progestins; Steroids | 1991 |
[Effect of the GnRH analog buserelin on sex hormone serum level in relation to treatment onset and duration].
Topics: Adult; Androstenedione; Buserelin; Dehydroepiandrosterone; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gamete Intrafallopian Transfer; Gonadal Steroid Hormones; Humans; Infertility, Female; Luteinizing Hormone; Ovulation Induction; Progesterone; Prolactin; Testosterone | 1991 |
Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.
Topics: Adult; Androstenedione; Buserelin; Estradiol; Female; Glucose; Growth Hormone; Humans; Hyperinsulinism; Obesity; Polycystic Ovary Syndrome; Somatomedins; Testosterone | 1990 |
Effect of long-term inhibition of gonadotrophin secretion by the gonadotrophin-releasing hormone agonist, buserelin, on sex steroid secretion and ovarian morphology in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Buserelin; Depression, Chemical; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Hypothalamus; Luteinizing Hormone; Ovary; Ovulation; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone | 1990 |
Suppression of plasma androgens by the antiandrogen flutamide in prostatic cancer patients treated with Zoladex, a GnRH analogue.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androgens; Androstenedione; Anilides; Antineoplastic Agents; Buserelin; Dehydroepiandrosterone; Depression, Chemical; Flutamide; Goserelin; Humans; Hydroxyprogesterones; Male; Orchiectomy; Prostatic Neoplasms; Testosterone | 1990 |
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1990 |
Study of the source(s) of hyperandrogenism in women with idiopathic hirsutism.
Topics: Adolescent; Adrenal Glands; Adult; Androstenedione; Buserelin; Dehydroepiandrosterone; Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Pituitary Hormone-Releasing Hormones; Testosterone | 1990 |
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen | 1989 |
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer.
Topics: Adult; Androstenedione; Breast Neoplasms; Buserelin; Estrone; Female; Goserelin; Humans; Middle Aged; Testosterone | 1989 |
Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Buserelin; Cells, Cultured; Cholesterol, LDL; Estradiol; Female; Follicle Stimulating Hormone; Granulosa Cells; Humans; Hydroxyprogesterones; Progesterone; Testosterone | 1988 |
Effects of LH suppression in polycystic ovary syndrome.
Topics: Adult; Androstenedione; Buserelin; Depression, Chemical; Estradiol; Estrone; Female; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Testosterone | 1985 |
Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Buserelin; Castration; Dihydrotestosterone; Dogs; Estrogens; Hydroxyprogesterones; Male; Progesterone; Prostatic Hyperplasia; Testis; Testosterone | 1984 |
Effect of treatment for 1 year with a luteinizing hormone-releasing hormone agonist on ovarian, thyroidal, and adrenal function and menstruation in the stumptailed monkey (Macaca arctoides).
Topics: Adrenal Glands; Androstenedione; Animals; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Macaca; Menstruation; Ovary; Progesterone; Thyroid Gland | 1983 |
Stimulation of androstenedione and progesterone release by LHRH and LHRH agonist from isolated rat preovulatory follicles.
Topics: Androstenedione; Animals; Buserelin; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Female; Gonadotropin-Releasing Hormone; Ovarian Follicle; Progesterone; Rats; Rats, Inbred Strains; Time Factors | 1983 |
Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Androstenedione; Anovulation; Buserelin; Dexamethasone; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Hydroxyprogesterones; Luteinizing Hormone; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Testosterone | 1995 |
The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Buserelin; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Glucose Tolerance Test; Hormones; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Luteinizing Hormone; Male; Octreotide; Polycystic Ovary Syndrome; Testosterone | 1996 |
Ovarian function in women with non-insulin dependent diabetes mellitus.
Topics: Adult; Androstenedione; Buserelin; Diabetes Mellitus, Type 2; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Obesity; Ovary; Testosterone | 1996 |
The value of human growth hormone as an adjuvant for ovarian stimulation in a human in vitro fertilization program.
Topics: Androstenedione; Buserelin; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Luteinizing Hormone; Ovulation Induction; Pregnancy; Progesterone; Testosterone | 1996 |
The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androstenedione; Buserelin; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric | 1999 |
The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome.
Topics: Androstenedione; Buserelin; Drug Resistance; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Recombinant Proteins; Sex Hormone-Binding Globulin; Sperm Injections, Intracytoplasmic; Testosterone; Treatment Outcome | 2001 |
Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage.
Topics: Androstenedione; Antibiotics, Antineoplastic; Buserelin; Dose-Response Relationship, Drug; Doxorubicin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Granulosa Cells; Humans; Leuprolide | 2007 |